BioMarin Rolls Up Sleeves To Prepare For Roctavian’s EU Debut

Positive CHMP Opinion Makes Approval Likely

 
• By Alaric DeArment
BioMarin announced a positive CHMP opinion for Roctavian, its gene therapy for hemophilia A • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies